FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004130102> ?p ?o ?g. }

• W2004130102 endingPage "e22" @default.
• W2004130102 startingPage "e22" @default.
• W2004130102 abstract "Recent findings in molecular biology implicate the involvement of proprotein convertase subtilisin/kexin type 9 (PCSK9) in low-density lipoprotein receptor (LDLR) protein regulation. The cholesterol-lowering potential of anti-PCSK9 antisense oligonucleotides (AONs) modified with bridged nucleic acids (BNA-AONs) including 2',4'-BNA (also called as locked nucleic acid (LNA)) and 2',4'-BNA(NC) chemistries were demonstrated both in vitro and in vivo. An in vitro transfection study revealed that all of the BNA-AONs induce dose-dependent reductions in PCSK9 messenger RNA (mRNA) levels concomitantly with increases in LDLR protein levels. BNA-AONs were administered to atherogenic diet-fed C57BL/6J mice twice weekly for 6 weeks; 2',4'-BNA-AON that targeted murine PCSK9 induced a dose-dependent reduction in hepatic PCSK9 mRNA and LDL cholesterol (LDL-C); the 43% reduction of serum LDL-C was achieved at a dose of 20 mg/kg/injection with only moderate increases in toxicological indicators. In addition, the serum high-density lipoprotein cholesterol (HDL-C) levels increased. These results support antisense inhibition of PCSK9 as a potential therapeutic approach. When compared with 2',4'-BNA-AON, 2',4'-BNA(NC)-AON showed an earlier LDL-C-lowering effect and was more tolerable in mice. Our results validate the optimization of 2',4'-BNA(NC)-based anti-PCSK9 antisense molecules to produce a promising therapeutic agent for the treatment of hypercholesterolemia." @default.
• W2004130102 created "2016-06-24" @default.
• W2004130102 creator A5006151751 @default.
• W2004130102 creator A5018157399 @default.
• W2004130102 creator A5019913014 @default.
• W2004130102 creator A5028320463 @default.
• W2004130102 creator A5028921297 @default.
• W2004130102 creator A5030211078 @default.
• W2004130102 creator A5031692773 @default.
• W2004130102 creator A5054512723 @default.
• W2004130102 creator A5057074334 @default.
• W2004130102 creator A5060893463 @default.
• W2004130102 creator A5071692466 @default.
• W2004130102 creator A5083003749 @default.
• W2004130102 date "2012-01-01" @default.
• W2004130102 modified "2023-10-17" @default.
• W2004130102 title "Cholesterol-lowering Action of BNA-based Antisense Oligonucleotides Targeting PCSK9 in Atherogenic Diet-induced Hypercholesterolemic Mice" @default.
• W2004130102 cites W1976691226 @default.
• W2004130102 cites W1987486422 @default.
• W2004130102 cites W1987578671 @default.
• W2004130102 cites W1997730532 @default.
• W2004130102 cites W2000277299 @default.
• W2004130102 cites W2005738707 @default.
• W2004130102 cites W2007172221 @default.
• W2004130102 cites W2011857098 @default.
• W2004130102 cites W2024858641 @default.
• W2004130102 cites W2025787794 @default.
• W2004130102 cites W2030341081 @default.
• W2004130102 cites W2040089348 @default.
• W2004130102 cites W2040612932 @default.
• W2004130102 cites W2045995934 @default.
• W2004130102 cites W2054610237 @default.
• W2004130102 cites W2057674977 @default.
• W2004130102 cites W2058205407 @default.
• W2004130102 cites W2065590725 @default.
• W2004130102 cites W2067401769 @default.
• W2004130102 cites W2076180913 @default.
• W2004130102 cites W2078810890 @default.
• W2004130102 cites W2083292951 @default.
• W2004130102 cites W2083420496 @default.
• W2004130102 cites W2086184683 @default.
• W2004130102 cites W2087577664 @default.
• W2004130102 cites W2088707712 @default.
• W2004130102 cites W2096041374 @default.
• W2004130102 cites W2106010903 @default.
• W2004130102 cites W2110083155 @default.
• W2004130102 cites W2118535904 @default.
• W2004130102 cites W2127791131 @default.
• W2004130102 cites W2128705098 @default.
• W2004130102 cites W2129582474 @default.
• W2004130102 cites W2133380348 @default.
• W2004130102 cites W2138486337 @default.
• W2004130102 cites W2146544786 @default.
• W2004130102 cites W2147542963 @default.
• W2004130102 cites W2156116824 @default.
• W2004130102 cites W2158340752 @default.
• W2004130102 cites W2170467167 @default.
• W2004130102 cites W2186895858 @default.
• W2004130102 cites W2949449722 @default.
• W2004130102 cites W4252021281 @default.
• W2004130102 cites W4255764447 @default.
• W2004130102 doi "https://doi.org/10.1038/mtna.2012.16" @default.
• W2004130102 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3393380" @default.
• W2004130102 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23344002" @default.
• W2004130102 hasPublicationYear "2012" @default.
• W2004130102 type Work @default.
• W2004130102 sameAs 2004130102 @default.
• W2004130102 citedByCount "58" @default.
• W2004130102 countsByYear W20041301022012 @default.
• W2004130102 countsByYear W20041301022013 @default.
• W2004130102 countsByYear W20041301022014 @default.
• W2004130102 countsByYear W20041301022015 @default.
• W2004130102 countsByYear W20041301022016 @default.
• W2004130102 countsByYear W20041301022017 @default.
• W2004130102 countsByYear W20041301022018 @default.
• W2004130102 countsByYear W20041301022019 @default.
• W2004130102 countsByYear W20041301022020 @default.
• W2004130102 countsByYear W20041301022021 @default.
• W2004130102 countsByYear W20041301022022 @default.
• W2004130102 countsByYear W20041301022023 @default.
• W2004130102 crossrefType "journal-article" @default.
• W2004130102 hasAuthorship W2004130102A5006151751 @default.
• W2004130102 hasAuthorship W2004130102A5018157399 @default.
• W2004130102 hasAuthorship W2004130102A5019913014 @default.
• W2004130102 hasAuthorship W2004130102A5028320463 @default.
• W2004130102 hasAuthorship W2004130102A5028921297 @default.
• W2004130102 hasAuthorship W2004130102A5030211078 @default.
• W2004130102 hasAuthorship W2004130102A5031692773 @default.
• W2004130102 hasAuthorship W2004130102A5054512723 @default.
• W2004130102 hasAuthorship W2004130102A5057074334 @default.
• W2004130102 hasAuthorship W2004130102A5060893463 @default.
• W2004130102 hasAuthorship W2004130102A5071692466 @default.
• W2004130102 hasAuthorship W2004130102A5083003749 @default.
• W2004130102 hasBestOaLocation W20041301021 @default.
• W2004130102 hasConcept C104317684 @default.
• W2004130102 hasConcept C129312508 @default.
• W2004130102 hasConcept C14363569 @default.
• W2004130102 hasConcept C150903083 @default.

• next